Birlotib 150 Tablet


Uses of Birlotib Tablet

Birlotib 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.

Birlotib Tablet side effects

  • Nausea
  • Vomiting
  • Fatigue
  • Breathing difficulty
  • Abdominal pain
  • Edema (swelling)
  • Weight loss
  • Loss of appetite
  • Anemia (low number of red blood cells)
  • Infection
  • Bone pain
  • Constipation
  • Diarrhea
  • Fever
  • Stomatitis (Inflammation of the mouth)
  • Rash

How to use Birlotib Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Birlotib 150 Tablet is to be taken empty stomach.

How Birlotib Tablet works

Birlotib 150 Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Birlotib Tablet related warnings

Interaction with alcohol is unknown. Please consult your doctor.
Birlotib 150 Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Birlotib 150 Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
It is not known whether Birlotib 150 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Birlotib 150 Tablet is safe to use in patients with kidney disease. No dose adjustment of Birlotib 150 Tablet is recommended.
Use of this medicine is not advised in patients with severe kidney disease.
Birlotib 150 Tablet should be used with caution in patients with liver disease. Dose adjustment of Birlotib 150 Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Birlotib 150 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.

What if you miss a dose of Birlotib Tablet?

If you miss a dose of Birlotib 150 Tablet, skip it and continue with your normal schedule. Do not double the dose.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.
Birlotib 150 Tablet
Erlonat 150 Tablet
Natco Pharma Ltd
save 60%
save 60%
Tyrokinin 150mg Tablet
Dr Reddy's Laboratories Ltd
save 44%
Erlotib 150mg Tablet
Intas Pharmaceuticals Ltd
10% costlier
Erleva 150mg Tablet
Glenmark Pharmaceuticals Ltd
save 22%

Expert Advice

  • Erlotinib tablets should be taken either 1 hour before or 2 hours after ingestion of food.
  • Erlotinib is not recommended for children and adolescents under 18 years of age.
  • Stop smoking and use effective contraceptive measures while on erlotinib treatment.
  • Do not start erlotinib if you use contact lenses, have had eye problems (ulcers in front part of eye, dry eyes, inflammation in front part of eye), liver or kidney problems, Gilbert’s syndrome (liver disorder that causes increased bilirubin), intolerance to some sugars, are pregnant or breast-feeding.
  • Tell your doctor if you suffer from breathing difficulty associated with fever or cough, severe diarrhea, loss of appetite, nausea or vomiting, severe blistering or peeling of skin, severe pain in abdomen, acute or increasing pain and redness in eye, blurred vision or sensitivity to light, increased eye watering.

Patient Concerns

Questions Related to Birlotib

I want to know the symptoms of cancer as I am a smoker
Dr. Vijay Sharnangat
Cancer Specialist
Symptoms for cancer depends upon which organ involved. For smokers , definitely chronic , they have possibility to develop lung cancer, head and neck cancers, oesophagus cancer, pancreatic cancer, stomach cancer and so more on. General symptoms would be like loss of appetite, weight loss, low grade fever in some cases, chronic cough for long time.
Do you have any questions related to Birlotib 150 Tablet?


Q. Is Birlotib FDA approved?

Yes, Birlotib is approved by FDA

Q. How long does Birlotib work?

A single dose of Birlotib works for around 36 hours.

Q. Is Birlotib cytotoxic, chemotherapeutic drug, biologic or monoclonal antibody?

Birlotib is not a cytotoxic, chemotherapy drug, or monoclonal antibody. Birlotib is a biologic tyrosine kinase inhibitor

Q. Does Birlotib cause neutropenia?

Yes, Birlotib can cause neutropenia
Related Lab Tests

Related Ayurvedic Ingredients

Information last updated by Dr. Varun Gupta, MD Pharmacology on 10th Oct 2018.
The medicine details are for information purpose only. Consult a doctor before taking any medicine.
Manufacturer/Marketer Address
407-408, Sharda Chambers, New Marine Lines, Mumbai 400 020 (Maharashtra), New Marine Lines, Marine Lines, Mumbai, Maharashtra 400020
10 tablets in 1 strip